DNA RNA and Cells
18 February 2014
California Stem Cell Announces U.S. FDA Approval of Phase II Cancer Stem Cell Clinical Trial for Ovarian Cancer14 February 2014
SanBio Announces the First Public Presentation of Data from its On-going Human Clinical Trial of Cell Therapy for Chronic Stroke Disability14 February 2014
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy11 February 2014
OncoGenex Announces Target Number of Events Reached in Phase 3 SYNERGY Trial of Custirsen in Metastatic Castrate-Resistant Prostate Cancer10 February 2014
Sarepta Therapeutics Announces Positive Safety Results from Phase I Clinical Study of Marburg Drug Candidate5 February 2014
Audentes Therapeutics and Genethon Announce Agreement to Develop Treatment for Severe Genetic Disease X-Linked Myotubular Myopathy29 January 2014
Regado Biosciences, Inc., Demonstrates Safety of Early Sheath Removal in Patients Treated with REG1 in Phase 2b Study25 January 2014
PTC Therapeutics Provides Update on CHMP Opinion for Conditional Approval of Ataluren for Nonsense Mutation Duchenne Muscular Dystrophy23 January 2014
California Stem Cell Submits Phase II Clinical Trial Protocol to FDA for Treating Ovarian Cancer23 January 2014
Inovio Pharmaceuticals Unveils Potent New Immune Activator22 January 2014
ATL1102 for Stem Cell Mobilisation Trial Approval21 January 2014
Pluristem’s Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints16 January 2014
Cytonet Submits European Approval Application For Liver Cell Therapy To Treat Urea Cycle Disorders In Children14 January 2014
Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness14 January 2014
Rexahn Initiates Phase IIa Clinical Trial of Archexin® in Patients with Metastatic Renal Cell Carcinoma13 January 2014
Arcturus Therapeutics, Inc. Announces an RNAi Therapeutic Targeting Transthyretin-mediated Amyloidosis as its Flagship ProgramNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports